← Back to Search

Monoclonal Antibodies

Active for High Cholesterol (REASCEND Trial)

Phase 2
Waitlist Available
Research Sponsored by Arisaph Pharmaceuticals Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 wks
Awards & highlights

REASCEND Trial Summary

The objective of this study is to evaluate the efficacy and safety of ARI-3037MO compared to placebo in reducing low-density lipoprotein cholesterol (LDL-C) levels in subjects with dyslipidemia.

Eligible Conditions
  • High Cholesterol

REASCEND Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 wks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 wks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LDL-c
Secondary outcome measures
HDL-c
HbA1C
TG

REASCEND Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ActiveActive Control1 Intervention
ARI-3037MO (niacin analog) 3g bid for 24 wks
Group II: PlaceboPlacebo Group1 Intervention
Matching Placebo 3g bid for 24 wks

Find a Location

Who is running the clinical trial?

Arisaph Pharmaceuticals IncLead Sponsor
2 Previous Clinical Trials
91 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
2015. "Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02532218.
All > Cholesterol
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top